Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Zhongchao Inc. Announces Launch of Health Education Intelligent Content Production Platform 2023-03-30 20:00
ACROBiosystems' new strategic focus - streamlining the transition from preclinical development to commercialization 2023-03-30 18:54
Zylox-Tonbridge Announces Financial Results for 2022: Revenue Increases by 87.8% YOY to RMB 334 million and Gross Profit Reaches RMB 253 million 2023-03-30 15:49
ImmVira's oncolytic product MVR-C5252 targeting malignant glioma obtained NMPA's approval for Clinical Trial in China 2023-03-30 08:00
bitBiome and Kaken Pharmaceuticals sign joint research agreement on the discovery of drugs for infectious diseases 2023-03-29 22:00
CHINA LIFE INSURANCE COMPANY LIMITED ANNOUNCES 2022 ANNUAL RESULTS (H SHARES) 2023-03-29 21:22
Scivita Medical enters into Strategic Agreement with Boston Scientific in China 2023-03-29 21:08
Just Three Months Into 2023, United Imaging Says Four New Scanners in Multiple Imaging Modalities Are Now Commercially Available in the United States 2023-03-29 21:00
HanAll Biopharma Assigns Su-jin Park as Co-CEO to Drive Next Phase of Growth 2023-03-29 19:00
Fosun Pharma Announces its 15th Corporate Social Responsibility Report: Continuous Innovation for the Benefit of the Public 2023-03-29 14:06
Kintor Pharma Announces Completion of Subject Enrollment in Phase III Clinical Trial of KX-826 for Treatment of Male Androgenetic Alopecia in China 2023-03-28 21:41
PharmaBlock Receives 2023 ACS CMO Excellence in Green Chemistry Award 2023-03-28 20:00
Tigermed Reports Full Year 2022 Results 2023-03-28 19:09
Fosun Pharma Announces 2022 Annual Results: Achieved Steady Growth with Revenue from Record High Innovative Products and Global Commercialization Capability Improvement 2023-03-28 16:20
OncoVent, a Subsidiary of Hepalink, Enters into a License and Distribution Agreement with Orient EuroPharma for the Immunotherapeutic Candidate Oregovomab 2023-03-28 15:36
Acepodia to Present Preclinical Data of Gamma Delta T cell Therapy Candidate, ACE2016, an off-the-shelf EGFR-targeting γδ2 T cell therapy against EGFR-expressing solid tumors 2023-03-28 10:00
BJ Bioscience Announces Clinical Collaboration with MSD to Evaluate BJ-001 in Combination with KEYTRUDA® (pembrolizumab) 2023-03-28 09:19
Noul Co. Ltd - The RIGHT Foundation Commences Research and Development for Supporting Malaria Control 2023-03-27 21:00
Berry Genomics and Ajlan & Bros Holding Subsidiaries Establish a Joint Venture to Support 'Vision 2030' 2023-03-27 20:46
PharmaBlock Opens New R&D Facility in Pennsylvania -- Expanding Capacity to Deliver GMP Projects 2023-03-27 20:00
1 96 97 98 99 100 801